Skip to main content

Table 2 Profile of patients at their first clinic visit during reporting period Q2 2018 – Q4 2019, Dakar

From: Implementing a multisector public-private partnership to improve urban hypertension management in low-and middle- income countries

 

Diagnosed

Treated

Controlled BP (at the last visit)

Among all patients with data

Total N = 6056

%

Total N = 5236

%

Total N = 1016

%

Treated Crude OR (95% CI)

BP controlled Crude OR (95% CI)

Age (years)

 18–29

110

1·8

84

1·6

9

0·9

REF

REF

 30–44

797

13·2

652

12·5

115

11·3

1·4 (0·8, 2·3)

1·9 (0·9, 4·4)

 45–59

2017

33·3

1753

33·5

333

32·8

2·1 (1·2, 3·3) ¥¥

2·2 (1·1, 5·0) ¥

 60–69

1777

29·3

1584

30·3

334

32·9

2·5 (1·5, 4·1) ¥¥¥

2·6 (1·3, 5·9) ¥¥

 70–79

840

13·9

743

14·2

159

15·6

2·4 (1·4, 3·9) ¥¥¥

2·6 (1·3, 6·0) ¥¥

  ≥ 80

227

3·7

184

3·5

32

3·1

1·3 (0·7, 2·4)

1·8 (0·8, 4·6)

 Missing age information

288

4·8

236*

4·5

34*

3·3

NA

NA

Sex

      

REF: MEN

REF: MEN

 Women

4669

77·1

4071

77·8

806

79·3

1·3 (1·1, 1·5) ¥¥

1·2 (0·9, 1·4)

 Missing sex information

0

0·0

0

0·0

0

0·0

NA

NA

BP Categories (mmHg)

  < 120 and < 80 mmHg

146

2·4

132

2·5

41

4·0

REF

REF

 120–129 or 80–84 mmHg

313

5·2

280

5·3

85

8·4

0·9 (0·4, 1·8)

1·0 (0·6, 1·5)

 130–139 or 85–89 mmHg

656

10·8

563

10·8

152

15·0

0·6 (0·3, 1·2)

0·8 (0·5, 1·2)

 140–159 or 90–99 mmHg

2207

36·4

1923

36·7

427

42·0

0·7 (0·4, 1·3)

0·6 (0·4, 0·9) ¥

 160–179 or 100–109 mmHg

1527

25·2

1324

25·3

218

21·5

0·7 (0·4, 1·2)

0·4 (0·3, 0·6) ¥¥¥

  ≥ 180 or ≥ 110 mmHg

1112

18·4

986

18·8

90

8·9

0·8 (0·4, 1·5)

0·2 (0·1, 0·4) ¥¥¥

 Missing BP information

95

1·6

28***

0·5

3***

0·3

NA

NA

CV Riska

 Low

1119

18·5

1007

19·2

237

23·3

REF

REF

 Moderate/Intermediate

1564

25·8

1436

27·4

282

27·8

1·2 (0·9, 1·6)

0·8 (0·7, 1·0) ¥

 High

2459

40·6

2295

43·8

385

37·9

1·6 (1·2, 2·0) ¥¥¥

0·7 (0·6, 0·8) ¥¥¥

 Missing

914

15·1

498***

9·5

112***

11·0

NA

NA

  1. Chi-square test for statistical significance for missingness of patient characteristic data *p < 0·05, **p < 0·01, ***p < 0·001
  2. BP blood pressure, CI confidence intervals, CV cardiovascular, NA not applicable, OR odds ratio, REF reference
  3. aCV risk was defined according to city-specific guidelines (see S3)
  4. Crude odds ratios and 95% CIs estimated only among patients with non-missing data and rounded to one decimal place; ¥p < 0·05, ¥¥p < 0·01, ¥¥¥p < 0·001